Vaginal prolapse is a painful condition generally experienced by women who have undergone a hysterectomy. To surgically repair this condition, surgeons implant a mesh patch to the pelvic floor, reinforcing the vaginal wall.
C.F. Bard, the manufacturer of Avaulta, got approval in 2008 from the FDA for a 501(k) application allowing them to fast-track their mesh patch for approval without the proper standard testing that these kinds of products need. As a result, patients reported severe injuries and symptoms related to the procedure, raising questions about the safety of this implant.
Some of the reported complications of Bard Avaulta patches include:
The manufacturers of this product are quick to place blame on the surgeons who performed the procedure, but the experienced mesh lawsuit lawyers at Goldblatt Singer will fight to get you compensation for the injuries caused by Bard Avaulta Patch surgeries.
If you or someone you love is suffering from vaginal prolapse as a result of a Bard Avaulta Patch surgery, contact Goldblatt Singer today for a risk-free consultation. We’ve recovered over $400 million for injured people since 1949.
To protect you from COVID-19, we are offering a quick & easy remote intake process. LEARN MORE HERE